Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NeuroPace Inc Director's Dealing 2021

Oct 8, 2021

33194_dirs_2021-10-08_812b93f4-bbca-47f1-b749-782beeceda75.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21

Reporting Person: LACOB JOSEPH (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-21 Stock Option (Right to Buy) $17.00 A 21698 Acquired 2031-04-20 Common Stock (21698) Direct

Footnotes

F1: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.